MCAM and diabetic kidney disease: Clinical studies in patients with diabetic nephropathy, IgA nephropathy, renal cell carcinoma, kidney transplants, and chronic kidney disease show correlations between MCAM expression (both tissue and soluble MCAM fractions) and disease severity, progression, and mortality.